Background: Cancer of uterine cervix is a leading cause of mortality and morbidity among women worldwide. In developing countries this is the most common gynaecological cancer. The simplicity, effectiveness and versatility of Pap test have made it an integral part of routine clinical practice. Pap smear is a simple, safe, non-invasive and cost-effective method for the detection of pre-cancerous, cancerous and benign lesions of cervix. The use of Pap smear as a screening tool has reduced morbidity and mortality of cancer cervix patients.

Objective: Timely detection of cervical cancer by clinical examination and Pap smear is one of the most important steps to prevent mortality and morbidity at low reserve set up.

Method: This is a cross-sectional study of women attending GICE nursing home Gynaecology OPD, Kalyani, India from 1st January 2018 to 1st December 2020.

Results: Pap smear result shows about 61% women have nonspecific cervicitis, hyperplasia and dysplasia was found in 18% and 14% women respectively. Our study found LSIL in 11 women, HSIL in 16 and carcinoma in situ in 8 women.

Conclusion: Cervical carcinoma is a preventable disease, but there is no perfect screening test that has 100% sensitivity and specificity. Pap smear test can help early detection of cervical pathology.

Key Words: Pap smear, HSIL, Cervical cancer

Click Here For Reading Continue

For Download  :